de FUEL3D TECHNOLOGIES LTD
A 3D IMAGING PLATFORM FOR THE COLLECTION OF SUBCUTANEOUS TUMOUR DATA IN PRE-CLINICAL ONCOLOGY.
BioVolume® is the world’s first 3D imaging solution that has been developed in partnership with a world leading pharmaceutical company and wider industry for visualising and measuring subcutaneous tumour growth in pre-clinical oncology research. It was conceived to enable faster, smarter and more confident decisions to be made in the identification and development of new cancer therapeutics. Our ground-breaking platform rapidly and accurately captures and reconstructs 3D tumour surface changes, enabling the analysis of texture, colour, shape and volume. Combining the latest technologies to disrupt the industry’s approach to pre-clinical oncology research, BioVolume improves the traceability, accuracy and reproducibility of data while ensuring greater animal welfare in adherence with the 3Rs (Refinement, Reduction and Replacement).